Company Search:
Advanced Search
Sponsored Links
Evotec AG Company Snapshot
Evotec AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Evotec AG with three other pharmaceutical manufacturers in Europe: Biovet AD of Bulgaria (2015 sales of 201.56 million Bulgarian Lev [US$112.10 million] ), Alkaloid AD Skopje of Macedonia (7.86 billion Denar [US$138.81 million] ), and Eckert & Ziegler Strahlen- und Medizinte (140.05 million Euro [US$152.39 million] of which 48% was Isotope Products).

Sales Analysis. During the year ended December of 2015, sales at Evotec AG were 127.68 million Euro (US$138.93 million). This is an increase of 42.7% versus 2014, when the company's sales were 89.50 million Euro. Sales of Evt Innovate saw an increase of 46.2% in 2015, from 14.67 million Euro to 21.45 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Evotec AG
  Stock Performance Chart for Evotec AG
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 5.00
(Figures in Euro)
1 Week -0.7%   13 Weeks 1.8%  
4 Weeks 23.7%   52 Weeks 26.7%  
Evotec AG Key Data:
  Ticker: EVT Country: Germany
  Exchanges: DUS OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 127,677,000
(Year Ending Jan 2016).
Employees: 1,000
  Currency: Euro Market Cap: 662,743,155
  Fiscal Yr Ends: December Shares Outstanding: 132,548,631
  Share Type: Stammaktie Closely Held Shares: 17,209,414
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.